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Periodontitis results from the destructive inflammatory reaction of the host elicited by a bacterial 
biofilm adhering to the tooth surface and if left untreated, may lead to the loss of the teeth and the 
surrounding tissues, including the alveolar bone. Cementum is a specialized calcified tissue covering 
the tooth root and an essential part of the periodontium which enables the attachment of the 
periodontal ligament to the root and the surrounding alveolar bone. Periodontal ligament cells 
(PDLCs) represent a promising cell source for periodontal tissue engineering. Since cementogenesis 
is the critical event for the regeneration of periodontal tissues, this study examined whether 
inorganic stimuli derived from bioactive bredigite (Ca7MgSi4O16) bioceramics could stimulate the 
proliferation and cementogenic differentiation of PDLCs, and further investigated the involvement of 
the Wnt/β-catenin signalling pathway during this process via analysing gene/protein expression of 
PDLCs which interacted with bredigite extracts. Our results showed that the ionic products from 
bredigite powder extracts led to significantly enhanced proliferation and cementogenic 
differentiation, including mineralization–nodule formation, ALP activity and a series of 
bone/cementum-related gene/protein expression (ALP, OPN, OCN, BSP, CAP and CEMP1) of PDLCs in 
a concentration dependent manner. Furthermore, the addition of cardamonin, a Wnt/β-catenin 
signalling inhibitor, reduced the pro-cementogenesis effect of the bredigite extracts, indicating the 
involvement of the Wnt/β-catenin signalling pathway in the cementogenesis of PDLCs induced by 
bredigite extracts. The present study suggests that an entirely inorganic stimulus with a specific 
composition of bredigite bioceramics possesses the capacity to trigger the activation of the Wnt/β-
catenin signalling pathway, leading to stimulated differentiation of PDLCs toward a cementogenic 
lineage. The results indicate the therapeutic potential of bredigite ceramics in periodontal tissue 
engineering application. 
 
1 Introduction 
Periodontitis is an inflammatory disease of the periodontium caused by microorganisms and calculus 
accumulation on the oral biofilm, leading to destruction of the tooth supporting tissues.1 
Regeneration of the periodontal region is challenged by the complex immune–inflammatory 
response of the host, resulting in unsatisfactory outcomes in clinical cases using the currently 
available therapies.2 Ideal strategies should be able to repair and regenerate all damaged structures 
including the cementum, periodontal ligament and alveolar bone. Cementum is a mineralized tissue 
produced by cementoblasts during tooth root formation. As a crucial part of periodontium, 
cementum is attached to the alveolar bone by the periodontal ligament. Periodontal ligament is a 
fibrous connective tissue located between the tooth root and alveolar bone. Recent studies have 
demonstrated that periodontal ligament cells (PDLCs) share similar biological characteristics with 
bone marrow mesenchymal stromal cells (BMSCs),3 indicating that PDL is a reliable and robust 
progenitor cell source for periodontal tissue regeneration.4–6 More importantly, PDLCs have also 
been shown to undergo cementoblastic differentiation in vitro,7 and to potentially generate 
cementum-like tissue in vivo.8 
 
It is generally accepted that bioactive materials play an important role in regenerating the lost 
periodontal/bone tissues.9–14 Ideal biomaterials should possess the ability to stimulate the 
cementogenic/osteogenic differentiation of PDLCs and further shorten the healing time. 
Conventional Ca–P based hydroxyapatite and β-tricalcium phosphate bioceramics have been used 
for the regeneration of periodontal tissues due to their osteoconductivity and biocompatibility;15,16 
however, their degradation and mechanical properties are far from optimal. Our previous studies 
have shown that bredigite bioceramics with Ca7MgSi4O16 compositions could be a potential bone 
regeneration material due to their excellent apatite mineralization, degradation and improved 
mechanical strength compared to Ca–P bioceramics as well as the ability to support the attachment 
and proliferation of osteoblasts.17,18 However, it is unclear whether bredigite can be used for 
regenerating periodontal tissues. More importantly, the interactions of bredigite and PDLCs, 
including proliferation, cementogenic differentiation (gene expression and protein synthesis) and 
the possible molecular mechanism, are completely unknown. 
 
It is known that the Wnt family consists of 19 secreted glycoproteins that mediate developmental 
physiology by regulating cellular processes including proliferation, differentiation, and 
apoptosis.19,20 The canonical Wnt signalling pathway is one of the signalling cascades transduced 
by Wnt proteins, involving stabilization and nuclear accumulation of β-catenin, and activation of Wnt 
target genes.21 Essential roles of Wnt/β-catenin signalling in bone formation and tooth 
morphogenesis have been well established.22,23 However, little is known about the involvement of 
Wnt/β-catenin signalling in the PDLCs differentiation with the interaction of bioactive ceramics for 
the dental hard tissue formation, especially cementum tissue which has limited remodelling 
potential and is difficult to regenerate. Therefore, the purpose of this study was to investigate the 
osteogenic/cementogenic gene expression and protein synthesis of PDLCs cultured in serial bredigite 
extracts and to further explore the potential molecular mechanism during this process. 
 
2 Experimental section 
2.1 Synthesis of bredigite powders 
Bredigite powders were synthesized by a sol–gel method using tetraethyl orthosilicate ((C2H5O)4Si, 
TEOS, 98%, Sigma Aldrich), magnesium nitrate hexahydrate (Mg(NO3)2·6H2O, 98%, Sigma Aldrich) 
and calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, 99%, Sigma Aldrich) as raw materials according to 
our previous publication.17 The TEOS was mixed with water and 2 M HNO3 and hydrolyzed for 30 
min under stirring. Then, Mg(NO3)2·6H2O and Ca(NO3)2·4H2O were added into the mixture (molar 
ratio: Si/Mg/Ca = 4[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space 
(1/6-em)]7), and the reactants were stirred for 5 h at room temperature. After the reaction, the 
solution was maintained at 60 °C for 1 day and dried at 120 °C for 2 days to obtain the dry gel. The 
dry gel was ground and transferred into a corundum crucible and calcined at 1200 °C for 3 h. The 
obtained bredigite powders were sieved with a 250-mesh for further use. The powder size was 
around several tens of micrometers composed of 1 μm aggregated particles as shown in Fig. 1. 
SEM image of the calcined bredigite particles. 
 Fig. 1 SEM image of the calcined bredigite particles.  
2.2 Preparation and characterization of the dissolution extracts of bredigite powders 
The dissolution extracts of bredigite powders were prepared by soaking bredigite powders into 
Dulbecco's modified Eagle medium with low glucose (DMEM-LG; Gibco®, Life Technologies Pty Ltd, 
Australia) at a concentration of 200 mg mL−1 according to International Standard Organization 
(ISO/EN) 10993-5.24 After incubation at 37 °C for 24 h, the mixture was centrifuged and the 
supernatant was collected. Serial dilutions of extracts (100, 50, 25, 12.5 and 6.25 mg mL−1) were 
prepared using serum-free DMEM-LG. After sterilization using a 0.2 μm filter, the extracts containing 
10% v/v fetal bovine serum (FBS; In Vitro Technologies, Australia) and 1% v/v penicillin/streptomycin 
(P/S; Gibco®, Life Technologies Pty Ltd, Australia) were used for further cell culture experiments. 
DMEM-LG supplemented with 10% FBS and 1% P/S without addition of material extracts was used as 
a blank control (blank). 
 
The ionic concentrations of Ca, Mg and Si in the graded extracts were measured by inductive 
coupled plasma atomic emission spectrometry (ICP-AES) (Perkin-Elmer Optima 7000DV). The extract 
solution was introduced into the spectrometer, and it became atomized into a mist-like cloud. This 
mist was carried into the argon plasma with a stream of argon gas. The plasma (ionized argon) 
produced temperatures close to 7000 °C, which thermally excited the outer-shell electrons of the 
elements in the sample. The intensity of this emission is indicative of the concentration of the 
element within the sample. The pH values of the bredigite extracts were measured by a pH meter. 
2.3 Cell culture 
Isolation and culture of PDLCs were performed according to previously published protocols.25,26 
Impacted third molars were extracted from healthy adults (18–25 years old) after obtaining 
informed consent from each donor and research protocol approval from the Human Research Ethics 
Committee, Queensland University of Technology. The periodontal ligament was gently removed 
from the middle third of the root surface under sterile conditions. The tissue explants were 
transferred to a primary culture dish and supplemented with DMEM-LG containing 10% v/v FBS and 
1% v/v P/S. Cells were allowed to grow out of the explants in a humidified atmosphere of 95% air 
and 5% CO2 at 37 °C. After reaching 80% confluence, PDLCs were passaged and re-plated in cell 
culture flasks. Only PDLCs at passage 3 were used in the subsequent experiments. 
2.4 Proliferation of PDLCs cultured in bredigite extracts 
The proliferation of PDLCs in the bredigite powder extracts was examined with MTT assay, a method 
based on the mitochondrial succinic dehydrogenase of proliferating cells in which MTT is reduced to 
an insoluble purple formazan product. In brief, PDLCs were cultured in 96-well plates at an initial 
density of 5 × 103 cells in 200 μL of medium per well. Bredigite powder extracts at 6.25, 12.5, 25, 50, 
100 and 200 mg mL−1 were added in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio to DMEM-
LG containing 20% FBS, making the final FBS concentration 10% in each experimental group. On day 
1, 3 and 7, 20 μL of 0.5 mg mL−1 of MTT solution (Sigma-Aldrich, Australia) was added to each well 
and incubated at 37 °C to form formazan crystals. After 4 h, the medium was removed and replaced 
by dimethyl sulfoxide (DMSO; Sigma-Aldrich, Australia) to dissolve the formazan product. The 
absorbance was measured at 495 nm with a microplate reader (SpectraMax, Plus 384, Molecular 
Devices, Inc., USA). All the results were expressed as the optical density (OD) value minus the 
absorbance of blank wells and experiments were performed in triplicate. 
2.5 ALP activity of PDLCs cultured in bredigite extracts 
The relative ALP activity of PDLCs was assessed on day 7 and 14 after culturing in different 
concentrations of the bredigite powder extracts. Briefly, PDLCs were cultured in 24-well cell culture 
plates with a seeding density of 1 × 105 cells per well. At each time point, the cells were washed with 
PBS three times to remove the residual medium, and then lysed in 200 μL of 0.2% Triton X-100. 
Lysates were centrifuged at 14[thin space (1/6-em)]000 rpm for 5 min at 4 °C. 50 μL of the 
supernatant was mixed with 150 μL of ALP assay working solution according to the manufacturer's 
protocol (QuantiChrom™ Alkaline Phosphatase Assay Kit, BioAssay Systems, USA). The OD value was 
measured at 405 nm on a plate reader. The relative ALP activity was expressed as the changed OD 
value divided by the reaction time and the total protein content as measured by the bicinchoninic 
acid protein assay kit (Thermo Fisher Scientific, Australia). 
2.6 Alizarin Red S staining 
In order to identify mineralization nodules, Alizarin Red S staining was performed on day 7 after 
PDLCs had grown as a monolayer in a 6-well cell culture plate. The medium was removed and the 
cells were washed with PBS and fixed in 100% methanol for 10 min. After gently rinsing with distilled 
water, the cells were stained with 1% Alizarin Red S for 20 min and the excessive solution was then 
washed away. The samples were air dried and photos were taken under a light microscope (Eclipse 
TS100, Nikon Australia Pty Ltd). 
2.7 RNA extraction and real-time quantitative (RT-qPCR) analysis 
The effect of bredigite powder extracts on the cementogenic/osteogenic differentiation of PDLCs 
was assessed by RT-qPCR to measure the mRNA expression of alkaline phosphatase (ALP), 
osteocalcin (OCN), osteopontin (OPN), bone sialoprotein (BSP), cementum attachment protein (CAP) 
and cementum protein 1 (CEMP1) in all treatment groups. The involvement of the Wnt/β-catenin 
signalling pathway was also investigated by analysing the expression of axis inhibition protein 2 
(Axin2), beta-catenin (β-catenin) and Wingless-3a (Wnt3a). Total RNA was extracted from PDLCs 
cultured in different concentrations of the bredigite powder extracts with TRIzol Reagent (Ambion®, 
Life Technologies Pty Ltd, Australia). Complementary DNA was synthesized using a DyNAmo™ cDNA 
Synthesis Kit (Finnzymes, Genesearch Pty Ltd, Australia) following the manufacturer's instructions. 
The RT-qPCR primers (Table 1) were designed based on cDNA sequences from the NCBI. BLAST 
searches of GenBank were performed on the primer sequences to ensure specificity. RT-qPCR was 
performed on an ABI Prism 7300 Sequence Detection System (Applied Biosystems, Australia) using 
SYBR® Green detection reagent (Applied Biosystems, Australia). Briefly, cDNA samples (2.5 μL of 
1[thin space (1/6-em)]:[thin space (1/6-em)]10 diluted template for a total volume of 25 μL per 
reaction) were analysed for genes of interest and the GAPDH house keeping gene. All reactions were 
run in triplicate for three independent experiments. Dissociation curve analysis was performed to 
validate the absence of primer dimers and nonspecific PCR products. The mean cycle threshold (Ct) 
value of each target gene was normalized against the Ct value of GAPDH and the relative expression 
calculated using the following formula: 2−(normalized average Cts) × 104. 
Table 1 Primer sequences for the genes observed in this study 
Gene name  Forward sequences  Reverse sequences 
GAPDH  5′TCAGCAATGCCTCCTGCAC  5′TCTGGGTGGCAGTGATGGC 
ALP  5′TCAGAAGCTCAACACCAACG  5′TTGTACGTCTTGGAGAGGGC 
AXIN2  5′CCCCAAAGCAGCGGTGC  5′GCGTGGACACCTGCCAG 
BSP  5′CTGGCACAGGGTATACAGGGTTAG  5′ACTGGTGCCGTTTATGCCTTG 
CAP  5′CTGCGCGCTGCACATGG  5′GCGATGTCGTAGAAGGTGAGCC 
CEMP1  5′GGGCACATCAAGCACTGACAG  5′CCCTTAGGAAGTGGCTGTCCAG 
CTNNB  5′GCTACTGTTGGATTGATTCGAAATC  5′CCCTGCTCACGCAAAGGT 
OCN  5′CAGGCCAGCTGAGTCCTGAG  5′GGAAAGAAGGGTGCCTGGAGAG 
OPN  5′TCACCTGTGCCATACCAGTTAA  5′TGAGATGGGTCAGGGTTTAGC 
WNT3a  5′TGGACAAAGCTACCAGGGAGT  5′CCCACCAAACTCGATGTCCTC 
 
2.8 Protein extraction and western blotting 
Total protein was harvested by lysing the cells in a lysis buffer containing 20 mM HEPES (pH 7.4), 
10% glycerol, 1% Triton X-100, 2 mM EGTA and a phosphatase/protease inhibitor cocktail (Roche 
Products Pty. Ltd, Australia). The protein concentration was determined by the BCA Protein Assay Kit 
(Thermo Fisher Scientific, Australia). 10 μg protein from each sample was separated by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and then the separated protein was 
transferred to a nitrocellulose membrane (Pall Corporation, USA). After blocking for 1 h with 
Odyssey® blocking buffer (Millennium Science, Australia), the membranes were incubated with the 
primary antibodies against ALP (1[thin space (1/6-em)]:[thin space (1/6-em)]1000, rabbit anti-
human; Abcam, USA), OPN (1[thin space (1/6-em)]:[thin space (1/6-em)]1000, rabbit anti-human; 
Abcam, USA), OCN (1[thin space (1/6-em)]:[thin space (1/6-em)]2000, rabbit anti-human; Abcam, 
USA), CAP (1[thin space (1/6-em)]:[thin space (1/6-em)]1000, mouse anti-bovine; Santa Cruz 
Biotechnology, Inc., USA), CEMP1 (1[thin space (1/6-em)]:[thin space (1/6-em)]3000, goat anti-
human; Santa Cruz Biotechnology, Inc., USA), β-catenin (1[thin space (1/6-em)]:[thin space (1/6-
em)]1000, rabbit anti-human; Cell Signaling Technology, Inc., USA), Axin2 (1[thin space (1/6-
em)]:[thin space (1/6-em)]2000 rabbit anti-human; Abcam, USA), and α-Tubulin (1[thin space (1/6-
em)]:[thin space (1/6-em)]4000, rabbit anti-human; Abcam, USA) overnight at 4 °C. The membranes 
were washed three times for 20 min each in TBS containing 0.01% Tween-20, and then incubated 
with corresponding fluorescent secondary antibodies (Cell Signaling Technology, Inc., USA) at 1[thin 
space (1/6-em)]:[thin space (1/6-em)]2000 dilution for 1 h at room temperature. Targeted proteins 
were visualized using the Odyssey® infrared imaging system. Band intensities were quantified by 
scanning densitometry and analysed using ImageJ software. All western blotting analyses were 
repeated three times under the same conditions. 
2.9 The effect of the Wnt/β-catenin signalling pathway on the cementogenic/osteogenic 
differentiation of PDLCs cultured in bredigite extracts 
The effect of the Wnt/β-catenin signalling pathway on PDLCs cultured in bredigite powder extracts 
was further investigated with or without the presence of 10 μM cardamonin, a commercial Wnt/β-
catenin inhibitor (Merck, Australia). After 7 days of culture, Alizarin Red S staining was performed, 
and cells were collected and subjected to RT-qPCR and western blotting analysis using the same 
methods as described in Section 2.7 and 2.8. 
 
2.10 Statistical analysis 
Analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA). All the data were 
expressed as means ± standard deviation (SD) and were analysed using one-way ANOVA with a post 
hoc test. A p-value <0.05 was considered statistically significant. 
3 Results 
3.1 Analysis of Ca, Si and Mg concentration and pH value for bredigite extracts 
There was no Si ion in blank control, but there was an increase of Si ions in bredigite extracts as the 
extract concentrations increased from 6.25 to 200 mg mL−1. The Ca level in the bredigite extracts 
was confined in the range of 48–68 ppm. The Mg level of bredigite extracts was mostly within the 
range of 10–18 ppm, except for that at 200 mg mL−1 (Table 2). The pH value increased obviously 
with the increase of bredigite extract concentrations (Table 3). 
Table 2 The ionic concentrations of Ca, Mg and Si in bredigite extracts 
Ionic concentrations (ppm)  Extract concentrations (mg mL−1) 
200  100  50  25  12.5  6.26  0 (blank control) 
Si  155.7  77.9  38.9  19.5  9.7  4.9  0 
Ca  47.9  58.1  63.1  65.7  66.9  67.6  68.2 
Mg  0.94  9.87  14.33  16.57  17.68  18.24  18.8 
 
Table 3 The pH values of bredigite extracts and bredigite–DMEM in graded concentrations 
Extract concentrations (mg mL−1)  200  100  50  25  12.5  6.26  0 (blank 
control) 
Extract pH  12.19 ± 0.04  9.75 ± 0.01  8.71 ± 0.06  8.42 ± 0.10  8.15 ± 0.06 
 8.01 ± 0.04  7.31 ± 0.04 
Extract–DMEM pH  12.18 ± 0.03  9.68 ± 0.04  8.67 ± 0.10  8.40 ± 0.04  8.09 ± 0.05 
 7.88 ± 0.03  7.36 ± 0.06 
 
3.2 The effect of bredigite extracts on cell proliferation 
As determined by MTT assay, the proliferation of PDLCs increased remarkably in a time dependent 
manner in most treatment groups except the highest concentration group (200 mg mL−1). 
Significant increase of cell proliferation was found in PDLCs grown in the extract concentration of 
6.25 mg mL−1, 12.5 mg mL−1, 25 mg mL−1, 50 mg mL−1, and 100 mg mL−1 compared to that in the 
blank control on day 3 (Fig. 2, p < 0.05). A similar trend of enhanced proliferation was noted on day 7 
in 6.25 mg mL−1, 12.5 mg mL−1, and 25 mg mL−1 groups. However, cell proliferation in 200 mg 
mL−1 bredigite powder extracts decreased significantly on day 7 (p < 0.05). 
The effect of bredigite extracts on the proliferation of PDLCs. *: Significant difference (p < 0.05) 
compared to blank control on day 3. **: Significant difference (p < 0.05) compared to blank control 
on day 7. Blank control: the medium supplemented with 10% FBS without addition of material 
extracts. 
 Fig. 2 The effect of bredigite extracts on the proliferation of PDLCs. *: Significant difference 
(p < 0.05) compared to blank control on day 3. **: Significant difference (p < 0.05) compared to 
blank control on day 7. Blank control: the medium supplemented with 10% FBS without addition of 
material extracts.  
3.3 The effect of bredigite extracts on the ALP activity of PDLCs 
Total protein levels failed to show significant changes among different experimental groups. The 
relative ALP activity increased significantly after PDLCs were exposed to different concentrations of 
bredigite powder extracts compared to the blank control. Bredigite extracts at the concentrations of 
12.5–100 mg mL−1 significantly elevated the ALP activity in PDLCs on day 7 (Fig. 3, p < 0.05). 
Substantial increase of ALP activity in PDLCs cultured in the bredigite powder extracts (6.25–100 mg 
mL−1) for 14 days was also observed as shown in Fig. 3 (p < 0.05). No significant difference of ALP 
activity between day 7 and day 14 was noted (p > 0.05). 
The effect of bredigite extracts on the ALP activity of PDLCs. *: Significant difference (p < 0.05) 
compared to blank control on day 7. **: Significant difference (p < 0.05) compared to blank control 
on day 14. Blank control: the medium supplemented with 10% FBS without addition of material 
extracts. 
 Fig. 3 The effect of bredigite extracts on the ALP activity of PDLCs. *: Significant difference (p 
< 0.05) compared to blank control on day 7. **: Significant difference (p < 0.05) compared to blank 
control on day 14. Blank control: the medium supplemented with 10% FBS without addition of 
material extracts.  
3.4 The cementogenic/osteogenic differentiation of PDLCs cultured in bredigite extracts 
Results of RT-qPCR analysis showed that the ionic products from bredigite powder extracts in a wide 
concentration range substantially enhanced the cementogenic/osteogenic differentiation of PDLCs 
to various degrees. Compared to those grown in normal culture medium, PDLCs from the 
experimental groups showed dramatically increased expression of cementogenic/osteogenic genes, 
with the most significantly enhanced expression of ALP, OCN, OPN, BSP, CAP and CEMP1 in PDLCs 
cultured in 50 mg mL−1 bredigite extracts (Fig. 4, p < 0.05). 
The effect of bredigite extracts on osteogenic/cementogenic gene expression (ALP, OCN, OPN, BSP, 
CAP and CEMP1) of PDLCs. *: Significant difference (p < 0.05) compared to blank control on day 7. 
**: Significant difference (p < 0.05) compared to blank control on day 14. Blank control: the medium 
supplemented with 10% FBS without addition of material extracts. 
 Fig. 4 The effect of bredigite extracts on osteogenic/cementogenic gene expression (ALP, 
OCN, OPN, BSP, CAP and CEMP1) of PDLCs. *: Significant difference (p < 0.05) compared to blank 
control on day 7. **: Significant difference (p < 0.05) compared to blank control on day 14. Blank 
control: the medium supplemented with 10% FBS without addition of material extracts.  
3.5 Activation of the Wnt/β-catenin signalling pathway in PDLCs stimulated by bredigite extracts 
The expression of the Wnt/β-catenin signalling-related genes was analysed by RT-qPCR after 
culturing PDLCs in different concentrations of bredigite powder extracts for 7 and 14 days. The 
results showed that the expression of Wnt3a, β-catenin and Axin2 was significantly elevated when 
PDLCs were cultured in a wide concentration range of bredigite powder extracts compared to the 
blank control on both day 7 and 14 (Fig. 5, p < 0.05). 
The effect of bredigite extracts on the Wnt/β-catenin signalling pathway (Wnt3a, β-catenin, and 
Axin2) of PDLCs by RT-qPCR analysis. *: Significant difference (p < 0.05) compared to blank control 
on day 7. **: Significant difference (p < 0.05) compared to blank control on day 14. Blank control: 
the medium supplemented with 10% FBS without addition of material extracts. 
 Fig. 5 The effect of bredigite extracts on the Wnt/β-catenin signalling pathway (Wnt3a, β-
catenin, and Axin2) of PDLCs by RT-qPCR analysis. *: Significant difference (p < 0.05) compared to 
blank control on day 7. **: Significant difference (p < 0.05) compared to blank control on day 14. 
Blank control: the medium supplemented with 10% FBS without addition of material extracts.  
3.6 The effect of blockade of the Wnt/β-catenin signalling pathway on the cementogenic/osteogenic 
differentiation of PDLCs 
The effect of blockade of the Wnt/β-catenin signalling pathway on calcium deposition was observed 
by Alizarin Red S staining. As shown in Fig. 6, mineralized nodules could be detected in PDLCs 
cultured in 50 mg mL−1 of bredigite extracts; however, the supplementation of 10 μM cardamonin 
remarkably reduced the calcium deposition (Fig. 6). Since the 12.5 mg mL−1 and 50 mg mL−1 
bredigite powder extracts were most effective in stimulating the cementogenic/osteogenic 
differentiation of PDLCs, the following experiments were performed according to this condition with 
the supplementation of 10 μM cardamonin. RT-qPCR results showed that cardamonin had a 
significant inhibitory effect on the expression of the cementogenic/osteogenic genes in PDLCs 
cultured in bredigite extracts (Fig. 7, p < 0.05). Interestingly, it was noted that 10 μM of cardamonin 
could not completely abrogate the expression of cementogenic/ostegenic genes of PDLCs cultured in 
bredigite extracts compared to that of the control group (Fig. 7, p < 0.05). Western blotting analysis 
further confirmed the activation of the Wnt/β-catenin signalling pathway in PDLCs cultured in 
bredigite powder extracts, and the supplementation of cardamonin abrogated the positive effect of 
bredigite powder extracts on the cementogenic/osteogenic differentiation of PDLCs (Fig. 8). 
Alizarin Red S staining showing that blockade of the Wnt/β-catenin signalling pathway had a 
negative effect on the calcium deposition. (A) Blank control; (B) PDLCs cultured in 50 mg mL−1 of 
bredigite extracts supplemented with 10 μM cardamonin; (C) PDLCs cultured in 50 mg mL−1 of 
bredigite extracts. 
 Fig. 6 Alizarin Red S staining showing that blockade of the Wnt/β-catenin signalling pathway 
had a negative effect on the calcium deposition. (A) Blank control; (B) PDLCs cultured in 50 mg mL−1 
of bredigite extracts supplemented with 10 μM cardamonin; (C) PDLCs cultured in 50 mg mL−1 of 
bredigite extracts.  
 
The effect of blockade of the Wnt/β-catenin signalling pathway on the cementogenic/osteogenic 
differentiation of PDLCs cultured in the presence of bredigite extracts (12.5 and 50 mg mL−1) with or 
without 10 μM cardamonin on day 7 by RT-qPCR analysis. *: Significant difference (p < 0.05) 
compared to blank control without supplementation of cardamonin. **: Significant difference (p < 
0.05) compared to blank control with supplementation of 10 μM cardamonin. Blank control: the 
medium supplemented with 10% FBS without addition of material extracts. 
 Fig. 7 The effect of blockade of the Wnt/β-catenin signalling pathway on the 
cementogenic/osteogenic differentiation of PDLCs cultured in the presence of bredigite extracts 
(12.5 and 50 mg mL−1) with or without 10 μM cardamonin on day 7 by RT-qPCR analysis. *: 
Significant difference (p < 0.05) compared to blank control without supplementation of cardamonin. 
**: Significant difference (p < 0.05) compared to blank control with supplementation of 10 μM 
cardamonin. Blank control: the medium supplemented with 10% FBS without addition of material 
extracts.  
 
(A) Western blotting analysis of a series of proteins of PDLCs cultured in the presence of bredigite 
extracts (12.5 and 50 mg mL−1) with or without 10 μM cardamonin. Relative band intensity of (B) 
ALP, (C) OPN, (D) OCN, (E) CAP, (F) CEMP1, (G) β-catenin and (H) Axin2. Activation of the Wnt/β-
catenin signalling pathway in PDLCs cultured in bredigite powder extracts and the supplementation 
of cardamonin abrogated the cementogenic/osteogenic differentiation of PDLCs. 
 Fig. 8 (A) Western blotting analysis of a series of proteins of PDLCs cultured in the presence 
of bredigite extracts (12.5 and 50 mg mL−1) with or without 10 μM cardamonin. Relative band 
intensity of (B) ALP, (C) OPN, (D) OCN, (E) CAP, (F) CEMP1, (G) β-catenin and (H) Axin2. Activation of 
the Wnt/β-catenin signalling pathway in PDLCs cultured in bredigite powder extracts and the 
supplementation of cardamonin abrogated the cementogenic/osteogenic differentiation of PDLCs.
  
4 Discussion 
The present study showed that the ionic products from bredigite bioceramics significantly stimulated 
the proliferation, ALP activity, mineralization nodule formation and osteogenesis/cementogenesis-
related gene/protein expression of PDLCs. In addition, the supplementation of the Wnt/β-catenin 
signalling inhibitor significantly reduced the pro-cementogenesis effect of the bredigite extracts. Our 
results indicate that the stimulatory effect of bredigite bioceramics on the cementogenic/osteogenic 
differentiation of PDLCs may involve the activation of the Wnt/β-catenin signalling pathway, and 
bredigite bioceramics may be a promising bioactive material for periodontal tissue regeneration. 
 
The ideal biomaterial for periodontal tissue regeneration should have the following features: 
biocompatibility, biodegradability and cementogenesis/osteogenesis stimulation. It is known that 
periodontal tissue engineering is a complex process including the regeneration of the alveolar bone, 
root cementum, and periodontal ligament.27 It is of great importance to prepare proper 
bioceramics to release inorganic stimulus to stimulate the response of PDLCs for optimal periodontal 
tissue regeneration without the usage of additional growth factors, which are costly and may have 
potential health risk. In this study, Si, Ca and Mg-containing ionic products in bredigite extracts 
significantly stimulated the proliferation and osteogenic/cementogenic differentiation. As shown in 
Table 2, one of the significant differences between the bredigite extracts and blank control is the 
concentrations of Si ions. Previous studies reported that Si containing ionic products from silicate-
based biomaterials can significantly enhance the proliferation and osteogenic differentiation of 
BMSCs and osteoblasts.28–30 In a recent study, we demonstrated the positive effect of Si ions on 
osteogenic differentiation of BMSCs.31 Therefore, it is speculated that Si ions may play a critical role 
in enhancing the osteogenic/cementogenic differentiation of PDLCs. However, our study also found 
that Si, Ca and Mg-containing ionic products in bredigite extracts at 200 mg mL−1 inhibited PDLCs' 
viability, which may be likely due to the changes of pH values. Silver et al. reported that the pH 
values had multiple effects on cell metabolism and function.32,33 The high pH value was found to be 
responsible for the inhibition of cell proliferation.34 In the present study, since bredigite is a Ca, Mg 
and Si-containing bioceramic, the released SiO44− ions can lead to an alkaline environment. When 
the extract concentration was 200 mg mL−1, it was found that there were high concentrations of 
SiO44− ions (155.7 ppm) in the extracts, leading to the increasing values of pH. The pH value of 
bredigite extracts at 200 mg mL−1 reached 11.30, which could be the main factor inhibiting PDLC 
viability. 
 
Although the data obtained in our study demonstrated that the cementogenic/osteogenic 
stimulatory effect of bredigite powder extracts on PDLCs, at least partially, was due to the released 
ions, the molecular mechanism underlying ionic stimulation of cementogenic/osteogenic 
differentiation for PDLCs is still largely undefined. The canonical Wnt/β-catenin signalling pathway 
has been intensely studied in developmental biology, in which the activated Wnt proteins form a 
complex by binding to the frizzled (Fz) transmembrane receptors and the low-density lipoprotein 
receptor related protein (LRP5/6) co-receptors located on the cell surface.35,36 The binding of Wnt 
protein to its receptors leads to the inhibition of glycogen synthase kinase-3β (GSK-3β) and the 
stabilization and accumulation of β-catenin, which then translocates to the nucleus where it 
interacts with members of the T-cell factor (Tcf)/lymphoid enhancer factor (Lef) family of 
transcription factors, resulting in the activation of Wnt downstream target genes.37–39 A previous 
study showed that the Wnt/β-catenin signalling pathway regulated the osteogenic differentiation of 
BMSCs.31 In the present study, we investigated the activation of the Wnt/β-catenin signalling 
pathway in ionic stimulated cementogenic/osteogenic differentiation of PDLCs. The results showed 
that the Wnt/β-catenin signalling pathway was activated in response to the bredigite extracts. 
Furthermore, treatment with the Wnt/β-catenin inhibitor, cardamonin, led to a decrease in 
osteogenic gene expression of ALP, OCN, OPN and BSP, together with the reduced expression of 
cementogenic genes, CAP and CEMP1 as well as the corresponding protein synthesis. Collectively, 
the results indicated that ionic extracts of bredigite powder stimulated cementogenic/osteogenic 
differentiation of PDLCs via the activation of the Wnt/β-catenin signalling pathway. 
 
In this study, the experiments including the extracts preparation and the cell culture were 
performed according to the International Standard Organization (ISO/EN 10993-5), which has been 
widely used for evaluating the cytocompatibility of biomaterials. The aim of this study was to 
investigate how Ca, Mg and Si-containing ionic products from bredigite bioceramics affect the 
function of PDLCs and the role of these ions in osteogenesis and cementogenesis. It is believed that 
the in vitro study will provide important evidence for our further study of scaffolds. For example, 
how does the material chemistry of Ca–Mg–Si bioceramics influence the in vitro response of PDLCs? 
The knowledge is of great importance to study the mechanism of in vitro and in vivo osteogenesis 
and cementogenesis for Ca–Mg–Si system bioceramics. 
 
5 Conclusion 
In summary, the Ca, Mg and Si-containing bredigite extracts significantly enhanced the proliferation 
of PDLCs and exhibited a strong pro-cementogenic effect. The possible mechanism for the markedly 
stimulatory effect of bredigite extracts on the cementogenic differentiation of PDLCs is related to 
the activation of the Wnt/β-catenin signalling pathway. Bredigite bioceramics would have great 
potential in the periodontal tissue regeneration application due to their excellent 
osteogenic/cementogenic stimulation. 
  
Acknowledgements 
The authors would like to thank the Pujiang Talent Program of Shanghai (12PJ1409500), Recruitment 
Program of Global Young Talent, China (Dr Wu), Natural Science Foundation of China (Grant 
81201202) and ARC Discovery (DP120103697). 
 
 
References 
 
    A. B. Berezow and R. P. Darveau, Periodontol 2000, 2011, 55, 36–47     . 
    A. Murua, E. Herran, G. Orive, M. Igartua, F. J. Blanco, J. L. Pedraz and R. M. Hernandez, Int. J. 
Pharm., 2011, 407, 142–150        
    Y. Tamaki, T. Nakahara, H. Ishikawa and S. Sato, Odontology, 2012 , in press. 
    L. Liu, J. Ling, X. Wei, L. Wu and Y. Xiao, J. Endod., 2009, 35, 1368–1376     . 
    T. Kato, K. Hattori, T. Deguchi, Y. Katsube, T. Matsumoto, H. Ohgushi and Y. Numabe, J. Tissue Eng. 
Regener. Med., 2011, 5, 798–805        
    J. Nunez, S. Sanz-Blasco, F. Vignoletti, F. Munoz, H. Arzate, C. Villalobos, L. Nunez, R. G. Caffesse 
and M. Sanz, J. Periodontal Res., 2012, 47, 33–44        
    C. Wu, Y. Zhou, C. Lin, J. Chang and Y. Xiao, Acta Biomater., 2012, 8, 3805–3815        
    K. Ji, Y. Liu, W. Lu, F. Yang, J. Yu, X. Wang, Q. Ma, Z. Yang, L. Wen and K. Xuan, J. Periodontal Res., 
2013, 48, 105–116        
    L. L. Hench and J. M. Polak, Science, 2002, 295, 1014–1017        
    C. Wu, Y. Zhou, C. Lin, J. Chang and Y. Xiao, Acta Biomater., 2012, 8, 3805–3815        
    C. Wu, W. Fan, J. Chang and Y. Xiao, J. Mater. Chem., 2011, 21, 18300–18307    
    C. Wu, Y. Zhou, M. Xu, P. Han, L. Chen, J. Chang and Y. Xiao, Biomaterials, 2013, 34, 422–433        
    C. T. Wu, W. Fan, Y. H. Zhou, Y. X. Luo, M. Gelinsky, J. Chang and Y. Xiao, J. Mater. Chem., 2012, 22, 
12288–12295    
    C. T. Wu, P. P. Han, M. C. Xu, X. F. Zhang, Y. H. Zhou, G. D. Xue, J. Chang and Y. Xiao, J. Mater. 
Chem. B, 2013, 1, 876–885    
    U. W. Jung, J. S. Lee, W. Y. Park, J. K. Cha, J. W. Hwang, J. C. Park, C. S. Kim, K. S. Cho, J. K. Chai and 
S. H. Choi, J. Periodontal Implant Sci., 2011, 41, 285–292        
    P. Asvanund and P. Chunhabundit, Implant Dentistry, 2012, 21, 248–253     . 
    C. Wu and J. Chang, J. Biomater. Appl., 2007, 21, 251–263        
    C. Wu, J. Chang, J. Wang, S. Ni and W. Zhai, Biomaterials, 2005, 26, 2925–2931        
    K. M. Cadigan and M. Peifer, Cold Spring Harbor Perspect. Biol., 2009, 1, a002881     . 
    C. Luo, L. Li, J. R. Li, G. Yang, S. Ding, W. Zhi, J. Weng and S. B. Zhou, J. Mater. Chem., 2012, 22, 
15654–15664    
    B. T. MacDonald, K. Tamai and X. He, Dev. Cell, 2009, 17, 9–26        
    P. J. O'Shea, D. W. Kim, J. G. Logan, S. Davis, R. L. Walker, P. S. Meltzer, S. Y. Cheng and G. R. 
Williams, J. Biol. Chem., 2012, 287, 17812–17822        
    M. Aurrekoetxea, J. Lopez, P. Garcia, G. Ibarretxe and F. Unda, Biol. Cell, 2012, 104, 603–617        
    ISO/EN 10993-5. Biological evaluation of medical devices-part 5 tests for cytotoxicity, in vitro 
methods 8.2 tests on extracts, ISO/EN 10993-10995. Biological evaluation of medical devices-part 
10995 tests for cytotoxicity, in vitro methods 10998.10992 tests on extracts. 
    Y. Zhou, C. Wu and Y. Xiao, Acta Biomater., 2012, 8, 2307–2316        
    P. Han, C. Wu, J. Chang and Y. Xiao, Biomaterials, 2012, 33, 6370–6379        
    A. Nanci and D. D. Bosshardt, Periodontol 2000, 2006, 40, 11–28     . 
    L. Xia, Z. Zhang, L. Chen, W. Zhang, D. Zeng, X. Zhang, J. Chang and X. Jiang, Eur. Cells Mater., 2011, 
22, 68–82    
    C. T. Wu, J. Chang and W. Fan, J. Mater. Chem., 2012, 22, 16801–16809    
    C. Wu, Y. Zhang, W. Fan, X. Ke, X. Hu, Y. Zhou and Y. Xiao, J. Biomed. Mater. Res., Part A, 2011, 98, 
122–131     . 
    P. Han, C. Wu and Y. Xiao, Biomater. Sci., 2013, 1, 379–392    
    I. A. Silver, J. Deas and M. Erecinska, Biomaterials, 2001, 22, 175–185        
    C. Wu, Y. Ramaswamy, A. Soeparto and H. Zreiqat, J. Biomed. Mater. Res., Part A, 2008, 86, 402–
410     . 
    A. El-Ghannam, P. Ducheyne and I. M. Shapiro, Biomaterials, 1997, 18, 295–303        
    T. Reya and H. Clevers, Nature, 2005, 434, 843–850        
    L. Schweizer and H. Varmus, BMC Cell Biol., 2003, 4, 4     . 
    A. J. Mikels and R. Nusse, Oncogene, 2006, 25, 7461–7468        
    C. Y. Logan and R. Nusse, Annu. Rev. Cell Dev. Biol., 2004, 20, 781–810        
    P. Zhang, Z. Hong, T. Yu, X. Chen and X. Jing, Biomaterials, 2009, 30, 58–70        
 
